PEEL Therapeutics Competitors and Similar CompaniesClear all
PEEL Therapeutics's competitors and similar companies include Alpha Tau Medical, Coherus Oncology, Gossamer Bio and Foghorn Therapeutics.
 PEEL Therapeutics PEEL Therapeutics is a biotech company delivering anti-cancer protein nanoparticles.
|  Alpha Tau Medical Alpha Tau Medical focuses on research, development, and commercialization of diffusing alpha-emitters radiation therapy (DaRT) for the treatment of solid cancer tumors. |  Coherus Oncology Coherus BioSciences is a biopharmaceutical company that focuses on the research, development, and commercialization of cancer treatments. |  Gossamer Bio Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. |  Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors. | |
Founding Date | Founding Date 2015 | Founding Date 2016 | Founding Date 2010 | Founding Date 2015 | Founding Date 2016 |
Type | Type Private | Type Private | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Salt Lake City, US HQ Nesher, IL | Locations Tel Aviv-Yafo, IL HQ Boston, US | Locations Redwood City, US HQ Camarillo, US | Locations San Diego, US HQ Dublin 2, IE | Locations Cambridge, US HQ Cambridge, US |
Employees | Employees 166% decrease | Employees 1041% increase | Employees 14736% decrease | Employees 11820% increase | Employees 1123% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 85.6 m | Valuation ($) 208 m | Valuation ($) 452 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $42.2m (FY, 2025) | Revenue (est.) $48.5m (FY, 2025) | Revenue (est.) $30.9m (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income $168m (FY, 2025) | Net income ($170.4m) (FY, 2025) | Net income ($74.4m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 55m | Total funding raised $ 174.5m | Total funding raised $ 480m | Total funding raised $ 50m |
For sources of this data, please see the company profile
View Company Profiles
Alpha Tau Medical
HQ
Tel Aviv-Yafo, IL
Employees
104↑ 1% increase
Alpha Tau Medical focuses on research, development, and commercialization of diffusing alpha-emitters radiation therapy (DaRT) for the treatment of solid cancer tumors.
View companyCoherus Oncology
HQ
Redwood City, US
Employees
147↓ 36% decrease
Coherus BioSciences is a biopharmaceutical company that focuses on the research, development, and commercialization of cancer treatments.
View companyGossamer Bio
HQ
San Diego, US
Employees
118↑ 20% increase
Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations.
View companyFoghorn Therapeutics
HQ
Cambridge, US
Employees
112↓ 3% decrease
Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.
View company